John P. Sharp

2012 - Ligand Pharmaceuticals

In 2012, John P. Sharp earned a total compensation of $782.6K as Former VP, Finance and Chief Financial Officer at Ligand Pharmaceuticals, a 31% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$102,382
Option Awards$312,365
Salary$292,519
Stock Awards$72,350
Other$2,985
Total$782,601

Sharp received $312.4K in option awards, accounting for 40% of the total pay in 2012.

Sharp also received $102.4K in non-equity incentive plan, $292.5K in salary, $72.4K in stock awards and $3K in other compensation.

Rankings

In 2012, John P. Sharp's compensation ranked 7,131st out of 11,487 executives tracked by ExecPay. In other words, Sharp earned more than 37.9% of executives.

ClassificationRankingPercentile
All
7,131
out of 11,487
38th
Division
Manufacturing
2,554
out of 4,253
40th
Major group
Chemicals And Allied Products
652
out of 1,198
46th
Industry group
Drugs
449
out of 920
51st
Industry
Pharmaceutical Preparations
353
out of 700
50th
Source: SEC filing on March 12, 2015.

Sharp's colleagues

We found four more compensation records of executives who worked with John P. Sharp at Ligand Pharmaceuticals in 2012.

2012

John Higgins

Ligand Pharmaceuticals

Chief Executive Officer

2012

Nishan de Silva

Ligand Pharmaceuticals

Chief Financial Officer

2012

Matthew Foehr

Ligand Pharmaceuticals

Chief Operating Officer

2012

Charles Berkman

Ligand Pharmaceuticals

General Counsel

News

You may also like